« Back to Record
Citation APA

Megalizzi, V., Mathieu, V., Mijatovic, T., Gailly, P., Debeir, O., De Nève, N., Van Damme, M., Bontempi, G., Haibe-Kains, B., Decaestecker, C., Kondo, Y., Kiss, R., & Lefranc, F. (2007). 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs. Neoplasia (New York, N.Y.), 9(5), 358-369.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/51212

Megalizzi, V., Mathieu, V., Mijatovic, T., Gailly, P., Debeir, O., De Nève, N., Van Damme, M., Bontempi, G., Haibe-Kains, B., Decaestecker, C., Kondo, Y., Kiss, R., & Lefranc, F. (2007). 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs. Neoplasia (New York, N.Y.), 9(5), 358-369.